Home > Insider Trading > Filing (0001822359-23-000017)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822359	Docgo Inc.	DCGO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1331867	D Ely Tendler	C/O Docgo Inc. 35 West 35Th Street, Floor 6 New York NY 10001	General Counsel And Secretary	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-10-02	10,000	$1.59	33,088	No	4	M	Direct
Common Stock	Disposition	2023-10-02	10,000	$5.29	23,088	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase Common Stock	Disposition	2023-10-02	10,000	$0.00	10,000	$1.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,902			No	4	M	Direct

Footnotes

Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan").
Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
Sale of shares effected pursuant to the 10b5-1 Plan.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.39. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021.